Skip to the content
Altai Oncology - Softwarelogo darklogo light
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us
Altai Oncology - Softwarelogo darklogo light
carboplatin
Cancer Drugs

carboplatin

U. Darda Bayraktar, MD
2025-12-05
New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC
Altai Protocol Library

New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC

U. Darda Bayraktar, MD
2025-10-21
New Indication: Pembrolizumab with Platinum-5FU for Advanced Penile Cancer
Altai Protocol Library

New Indication: Pembrolizumab with Platinum-5FU for Advanced Penile Cancer

U. Darda Bayraktar, MD
2025-10-20
Non-Small Cell Lung Cancer

New Reference: Neoadjuvant Nivolumab for NSCLC

Ulas D. Bayraktar, MD
2025-09-08
Anal Cancer

New Reference: Retifanlimab + Chemotherapy for Advanced Anal Cancer

Ulas D. Bayraktar, MD
2025-09-08
Survival for atezolizumab with carboplatin and pemetrexed for pleural mesothelioma
Mesothelioma

New Protocol: Atezolizumab with Carbo-Pem-Bev for Pleural Mesothelioma

Ulas D. Bayraktar, MD
2025-05-04
Survival figure for toripalimab with chemotherapy for small cell lung cancer

New Protocol: Toripalimab with Chemotherapy for Small Cell Lung Cancer

Ulas D. Bayraktar, MD
2025-04-07

New Protocol: CARBOplatin-PACLitaxel + Atezolizumab for Thymic Carcinoma

Ulas D. Bayraktar, MD
2025-04-07
Uterine Cancer

New Protocol: Durvalumab with CARBOplatin and PACLitaxel for Endomterial Cancer

Ulas D. Bayraktar, MD
2024-06-21
Cervical Cancer

New Protocol: Tisotumab Vedotin in Combination with Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer

Ulas D. Bayraktar, MD
2023-06-07
  • Library
  • F.A.Q.
  • Contact Us

Privacy Policy

Altai, Inc (USA)

30 N Gould St, Ste 6801

Sheridan, WY, 82801, USA

Phone: +1 (978) 393 0042

Altay Tıp Sağlık Yazılım AŞ (Türkiye)

Mutlukent Mah Manuk Bey Sk No: 4

Çankaya, Ankara, 06800, Türkiye

Phone: +90 (312) 911 5735

Our Terms & Privacy Policy

Copyright - 2024 - Altai Inc - All rights reserved

Back to top Drag
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us

jghghjghjghhgj